E50 (Etoposide 50 mg)
Pill imprint E50 has been identified as Etoposide 50 mg.
Etoposide is used in the treatment of small cell lung cancer; ovarian cancer; hodgkin's lymphoma; cancer; testicular cancer and belongs to the drug class mitotic inhibitors. There is positive evidence of human fetal risk during pregnancy. Etoposide 50 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for E50 (Etoposide 50 mg)
- 50 mg
- 23.00 mm
- Prescription only
- Drug Class:
- Mitotic inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- citric acid anhydrous
ferric oxide red
|NDC Code||Manufacturer / Repackager|
|51079-0965||UDL Laboratories Inc|
|54868-5355||Physicians Total Care Inc (repackager)|
Note: Inactive ingredients may vary.
Etoposide is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...